Global Bladder Cancer Market Size By Type (Transitional Cell Bladder Cancer, Superficial Bladder Cancer, Invasive Bladder Cancer), By Treatment (Surgery, Chemotherapy), By End-Users (Hospitals, Cancer Centers), By Geographic Scope And Forecast

<p>Bladder Cancer Market size was valued at USD 54.07 Billion in 2024 and is projected to reach USD 78.2 Billion by 2031, growing at a CAGR of 4.72% during the forecast period 2024-2031.</p>
<p>Key Market Drivers:<br />
• Bladder Cancer Incidence: The World Health Organization reports that the global incidence of bladder cancer is gradually increasing, with an estimated 549,000 new cases recorded in 2018. According to the American Cancer Society, approximately 84,430 new cases of bladder cancer will be detected in the United States alone by 2023.<br />
• Aging Population: The global population is aging, and bladder cancer is more common among older persons. The National Cancer Institute estimates that the median age at diagnosis for bladder cancer is 73 years. As the population ages, the chance of acquiring bladder cancer is predicted to rise, increasing the need for effective treatment and management alternatives.<br />
• Rising Risk Factors: Smoking, chemical exposure, and persistent bladder infections have all been related to an increased risk of getting bladder cancer. The Centers for Disease Control and Prevention (CDC) believes that smoking causes around 50% of bladder cancer cases in the United States.<br />
• Advancement in Diagnostic Techniques: Improved diagnostic procedures such as cystoscopy, urine cytology, and biomarker tests have allowed for earlier detection of bladder cancer, resulting in improved awareness and diagnosis rates. According to a study published in the Journal of the American Medical Association, the use of these advanced diagnostic technologies has led to an increase in the reported incidence of bladder cancer in recent years.</p>

{'p1': '膀胱癌市场规模在2024年达到了540.7亿美元，预计到2031年将增长至782亿美元，在预测期内（2024-2031年）以4.72%的复合年增长率稳步增长。', 'p2': '关键市场驱动因素：', 'p3': '• 膀胱癌发病率：世界卫生组织报告指出，全球膀胱癌发病率呈逐渐上升趋势，2018年记录的新发病例约为54.9万。根据美国癌症协会的预测，仅在美国，到2023年将发现约84,430例新发膀胱癌病例。', 'p4': '• 人口老龄化：全球人口老龄化趋势明显，膀胱癌在老年人中更为常见。美国国家癌症研究所估计，膀胱癌的平均诊断年龄为73岁。随着人口老龄化，罹患膀胱癌的风险预计将增加，从而提高了对有效治疗和管理替代方案的需求。', 'p5': '• 危险因素增加：吸烟、化学物质暴露和持续的膀胱感染都与膀胱癌发病风险增加有关。美国疾病控制与预防中心（CDC）认为，吸烟在美国约导致50%的膀胱癌病例。', 'p6': '• 诊断技术进步：如膀胱镜检查、尿液细胞学和组织标志物检测等改进的诊断程序，使得膀胱癌的早期发现成为可能，从而提高了公众的意识和诊断率。根据《美国医学会杂志》发表的一项研究，近年来，这些先进的诊断技术的应用导致了报告的膀胱癌发病率有所上升。'}